凯发体育最新版 announces partnership with the Center for Contemporary Sciences
凯发体育最新版, a BICO 公司, announced today its partnership with the Center for Contemporary Sciences (CCS), an organization founded by scientists to champion and advance more human-relevant testing methods with industry, 政策, 和监管机构. 凯发体育最新版 will take on a scientific advisory role and lend its industry expertise in existing human-relevant testing methods.
The Center for Contemporary Sciences’ goal is to educate, 连接, and support the scientific research industry with modern innovations that replace animal testing. With a science-driven mission that recognizes that animal models are not translatable to human biology, CCS places emphasis on human-relevant methods that currently exist or can be developed, to provide a more accurate human response and bring safer, more efficacious products to market for consumers.
CCS’s mission complements 凯发体育最新版’s mission to support human-relevant research by providing synergistic life science products and services. 凯发体育最新版’s suite of lab-grown human tissue models, 包括皮肤, 眼睛, 呼吸, 肠道, and 阴道 tissue types, are micro-physiological platforms that recapitulate human biology better than those of whole-animal or animal-derived models, providing a more accessible, 具有成本效益的, and biologically comparable approach to preclinical evaluation for the pharmaceutical, 化妆品, and consumer goods industries.
“目前, nine out of ten drug formulations that pass the animal tests in preclinical screening will fail in human clinical trials, partly because animal models are not translatable to human biology,” 凯文堤道, Vice President of Business Development for 凯发体育最新版生命科学. “Our mission overlaps with CCS’s mission to bring better scientific tools to the preclinical testing process that can reduce clinical failures and ultimately bring safer, more efficacious products to market.”他补充道, “Partnering with CCS to provide consultation on feasible and accessible alternatives for their partners seamlessly blends with our mission and initiatives.”
“The science overwhelmingly shows that animal tests are poorly predictive of human outcomes,” says CCS CEO and Co-founder Aysha Akhtar，医学博士，公共卫生硕士. “Patients are desperately in need of treatments that work, and lives remain in the balance as long as we continue unreliable animal testing. We need better methods, and we need them now. Replacing animal testing is a win-win for humans and animals and we are incredibly grateful for the immense experience 凯发体育最新版 brings in human-relevant testing methods.”
凯发体育最新版MATTEK 成立于1985年, 凯发体育最新版生命科学 began producing three-dimensional human tissue models as reliable replacements for animal testing. 凯发体育最新版’s physiologically advanced tissue models empower companies in the 化妆品, 化学, and pharmaceutical industries to achieve their goals of non-animal testing while lowering preclinical costs and providing human-relevant results. With locations in Ashland, MA, 美国, 和伯拉第斯拉瓦, Slovakia today 凯发体育最新版’s offerings include skin, 眼睛, 口服, 呼吸, 阴道, and intestinal tissue models including disease modeling, 验证, and custom testing services, multiple donor primary cells, 文化传媒, and highly optical cultureware.
ABOUT THE CENTER FOR CONTEMPORARY SCIENCES CCS a nonprofit organization founded in 2020, is pioneering a paradigm shift towards innovative, evidence-based research methods that are based on human biology. 通过合作, we champion technologies that are better for humans and that replace animal testing.
联系信息
For further information, please contact:
Margaux Babineau, Director of Marketing & 客户互动
Phone (US): +1 (508) 881-6771 X 218
电子邮件: mbabineau@shisanyiyuan.com
